Nephrol Dial Transplant (1994) 9: 1418-1425
© 1994 European Renal Association-European Dialysis and Transplant Association
research-article
Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
1Sheffield Kidney Institute Sheffield, UK 2Department of Histopathology, Northern General Hospital Sheffield, UK
Correspondence and offprint requests to: Correspondence and offprint requests to: Dr A. M. El Nahas, PhD, FRCP, Sheffield Kidney Institute, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK
The limited knowledge of the cellular mediators of renal scarring hampers progress in the management of progressive chronic renal failure (CRF). We have studied 38 patients with biopsy-proven mesangial IgA nephropathy with emphasis on attempting to define the role of myofibroblasts(
-smooth muscle actin/SMA-positive cells) in renal scarring. In 18 untreated patients, correlations were undertaken between known histological parameters of progression as well as the presence of myofibroblasts in tissues and the clinical outcome. -SMA staining by an avidin-biotin-peroxidase method was confined to a large extent to the vascular smooth muscle cells of normal kidneys but extended to the tubulointerstitium and periglomerular space in scarred kidneys. Mild glomerular staining was also noted. The interstitial immunostain followed a similar distribution to that of interstitial type III collagen. Morphometric analysis showed the interstitial SMA staining to be a reliable histological predictor of outcome as it discriminated between progressors and non-progressors (
2=4.923, P=0.026). The intensity of the interstitial -SMA staining correlated with renal functional outcome; inversely with the reciprocal of serum creatinine slopes (r=-0.466, P<0.025) and positively with the serum creatinine value at the end of the observation period (r=0.704, P<0.00l). Other histological parameters that correlated with outcome included the degree of tubulointerstitial (TI) inflammatory infiltrate (r=-0.425, P<0.05 with 1/Cr slope and r=0.760, P< with serum creatinine) and the intensity of the TI staining for collagen IV (r=-0.567 and 0.667 respectively). In 20 patients treated with prednisolone and azathioprine, a second renal biopsy showed the persistence of interstitial myofibroblasts in the absence of progressive fibrosis. In conclusion, staining of renal biopsies of patients with mesangial IgA for -SMA-positive cells may identify the myofibroblasts as important mediators of TI scarring and have useful prognostic implications.
Keywords: myofibroblasts; -smooth muscle actin; mesangial IgA nephropathy; chronic renal failure (CRF); glomeruloscierosis; tubulointerstitial fibrosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Li, J. A. Deane, N. V. Campanale, J. F. Bertram, and S. D. Ricardo The Contribution of Bone Marrow-Derived Cells to the Development of Renal Interstitial Fibrosis Stem Cells, March 1, 2007; 25(3): 697 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, N. V. Campanale, R. J. Liang, J. A. Deane, J. F. Bertram, and S. D. Ricardo Inhibition of p38 Mitogen-Activated Protein Kinase and Transforming Growth Factor-{beta}1/Smad Signaling Pathways Modulates the Development of Fibrosis in Adriamycin-Induced Nephropathy Am. J. Pathol., November 1, 2006; 169(5): 1527 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, D. Fraser, and A. Phillips ERK, p38, and Smad Signaling Pathways Differentially Regulate Transforming Growth Factor-{beta}1 Autoinduction in Proximal Tubular Epithelial Cells Am. J. Pathol., October 1, 2006; 169(4): 1282 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Stallone, B. Infante, A. Schena, M. Battaglia, P. Ditonno, A. Loverre, L. Gesualdo, F. P. Schena, and G. Grandaliano Rapamycin for Treatment of Chronic Allograft Nephropathy in Renal Transplant Patients J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3755 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takeji, N. Kawada, T. Moriyama, K. Nagatoya, S. Oseto, S. Akira, M. Hori, E. Imai, and T. Miwa CCAAT/Enhancer-Binding Protein {delta} Contributes to Myofibroblast Transdifferentiation and Renal Disease Progression J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2383 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bariety, G. S. Hill, C. Mandet, T. Irinopoulou, C. Jacquot, A. Meyrier, and P. Bruneval Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1777 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Johnson, A. F. El-Koraie, N. J. Skill, N. M. Baddour, A. M. El Nahas, M. Njloma, A. G. Adam, and M. Griffin Tissue Transglutaminase and the Progression of Human Renal Scarring J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2052 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cheng and D. H. Lovett Gelatinase A (MMP-2) Is Necessary and Sufficient for Renal Tubular Cell Epithelial-Mesenchymal Transformation Am. J. Pathol., June 1, 2003; 162(6): 1937 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, P. Carmeliet, and A. A. Eddy Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1234 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Thomas, A. Clayton, J. Thomas, M. Davies, and R. Steadman Structural and Functional Changes in Heparan Sulfate Proteoglycan Expression Associated with the Myofibroblastic Phenotype Am. J. Pathol., March 1, 2003; 162(3): 977 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Blaber, E. Stylianou, A. Clayton, and R. Steadman Selective Regulation of ICAM-1 and RANTES Gene Expression after ICAM-1 Ligation on Human Renal Fibroblasts J. Am. Soc. Nephrol., January 1, 2003; 14(1): 116 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Goumenos, S. Tsakas, A. M. El Nahas, S. Alexandri, S. Oldroyd, P. Kalliakmani, and J. G. Vlachojannis Transforming growth factor-{beta}1 in the kidney and urine of patients with glomerular disease and proteinuria Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2145 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Badid, A. Desmouliere, D. Babici, A. Hadj-Aissa, B. McGregor, N. Lefrancois, J. L. Touraine, and M. Laville Interstitial expression of {alpha}-SMA: an early marker of chronic renal allograft dysfunction Nephrol. Dial. Transplant., November 1, 2002; 17(11): 1993 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. T Weber and Yao Sun Recruitable ACE and tissue repair in the infarcted heart Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 295 - 303. [PDF]
|
|
|
|
 |
|
 Y. Sun and K. T. Weber Infarct scar: a dynamic tissue Cardiovasc Res, May 1, 2000; 46(2): 250 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Ng, J.-M. Fan, W. Mu, D. J. Nikolic-Paterson, W.-C. Yang, T.-p. Huang, R. C. Atkins, and H. Y. Lan Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2860 - 2872. [Abstract] [Full Text] [PDF]
|
|